Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

PROCEPT BioRobotics Expects FY23 Revenue Of $135.9M-$136.2M Vs. Prior Guidance $133.5M, Consensus $133.51M

Author: Benzinga Newsdesk | January 08, 2024 06:12pm

Posted In: PRCT